BEIJING (Reuters) – China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021, Chairman Liu Jingzhen said at a government press conference on Tuesday.
(Reporting by Roxanne Liu and Tony Munroe, editing by Louise Heavens)
